The SERVE-HF safety notice in clinical practice - experiences of a tertiary sleep center.


BACKGROUND In May 2015, the results of the SERVE-HF trial - addressing adaptive servoventilation (ASV) in chronic congestive heart failure (CHF) patients with central sleep apnea (CSA) - prompted a field safety notice. It was recommended to identify CHF patients treated with ASV and to advise the discontinuation of the treatment. We aimed to analyze the… (More)
DOI: 10.1016/j.sleep.2017.02.007


2 Figures and Tables